0 Table of Contents |
1 Home |
2 IDMP Standard ISO 11615 |
3 Datasource Authorised Medicinal Product |
4 Dataexport FOPH Spezialitätenliste |
5 Use Cases |
6 Cuprior |
7 Entocort |
8 Estalis |
9 Keytruda |
10 Paxlovid |
11 Triogen |
12 Profiles |
13 Extensions |
14 Terminology |
15 Changelog |
16 Artifacts Summary |
16.1 CH EPL Organization |
16.2 CH IDMP AdministrableProductDefinition |
16.3 CH IDMP ClinicalUseDefinition Indication |
16.4 CH IDMP DocumentReference |
16.5 CH IDMP ManufacturedItemDefinition |
16.6 IDMP Bundle |
16.7 IDMP Ingredient |
16.8 IDMP MedicinalProductDefinition |
16.9 IDMP PackagedProductDefinition |
16.10 IDMP RegulatedAuthorization |
16.11 FOPH Dossier Number |
16.12 GLN Identifier |
16.13 LOC Identifier |
16.14 CH - EPL Full Limitation Text |
16.15 CH - EPL Product Price |
16.16 CH - EPL Regulated Authorization Limitation |
16.17 CH - EPL Reimbursement SL |
16.18 CH - SMC Authorized Dose Form |
16.19 CH - Authorisation Type |
16.20 CH - Medicinal Product Name Type |
16.21 CH - Product Characteristics Type |
16.22 CH EPL - Gamme |
16.23 CH EPL - Limitation Status |
16.24 CH EPL - Listing Status |
16.25 CH EPL - Other Characteristics Packaged Item |
16.26 CH EPL - Price Type |
16.27 CH EPL - Product Type |
16.28 CH EPL - Reimbursement Status |
16.29 CH EPL - Type of Price Change |
16.30 CH SMC - Attached Document Type |
16.31 CH SMC - Authorisation Status |
16.32 CH SMC - Authorised Pharmaceutical Dose Form |
16.33 CH SMC - Ingredient Role |
16.34 CH SMC - Legal Status of Supply |
16.35 CH SMC - Marketing Status |
16.36 CH SMC - Pediatric Use Indicator |
16.37 CH SMC - Special Precautions for Storage |
16.38 CH SMC - Substance |
16.39 CH SMC - TherapeuticProductcode |
16.40 CH SMC- Additional Monitoring Indicator |
16.41 EDQM - Combination Packaging |
16.42 EDQM - Combined Pharmaceutical Dose Form |
16.43 EDQM - Combined Term |
16.44 EDQM - Packaging |
16.45 EDQM - Pharmaceutical Dose Form |
16.46 EDQM - Route Of Administration |
16.47 EDQM - Unit of Presentation |
16.48 EMA - Domain |
16.49 EMA - Intended Effect |
16.50 EMA - Shelf Life Type |
16.51 CH - Authorisation Type |
16.52 CH - Medicinal Product Name Type |
16.53 CH - Product Characteristics Type |
16.54 CH EPL - Gamme |
16.55 CH EPL - Limitation Status |
16.56 CH EPL - Listing Status |
16.57 CH EPL - Other Characteristics Packaged Item |
16.58 CH EPL - Price Type |
16.59 CH EPL - Product Type |
16.60 CH EPL - Reimbursement Status |
16.61 CH EPL - Type of Price Change |
16.62 CH SMC - Additional Monitoring Indicator |
16.63 CH SMC - Attached Document Type |
16.64 CH SMC - Authorisation Status |
16.65 CH SMC - Ingredient Role |
16.66 CH SMC - Legal Status of Supply |
16.67 CH SMC - Marketing Status |
16.68 CH SMC - Pediatric Use Indicator |
16.69 CH SMC - Special Precautions for Storage |
16.70 CH SMC - Substance |
16.71 CH SMC - TherapeuticProductcode |
16.72 EDQM - Standard Terms |
16.73 EMA - RMS |
16.74 5204201 |
16.75 52042011 |
16.76 5470402 |
16.77 54704089 |
16.78 66231001 |
16.79 6623101 |
16.80 67431001 |
16.81 6743101 |
16.82 67719001 |
16.83 6771901 |
16.84 68793001 |
16.85 6879301 |
16.86 CH-52042011 |
16.87 CH-54704089 |
16.88 CH-66231001 |
16.89 CH-67431001 |
16.90 CH-68291001 |
16.91 CH-68793001 |
16.92 CUPRIOR Filmtabl 150 mg 72 Stk |
16.93 CUPRIOR Filmtabl 150 mg 72 Stk (Bundle) |
16.94 Cuprior, Filmtabletten Fachinformation |
16.95 Cuprior, Filmtabletten Patienteninformation |
16.96 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk |
16.97 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle) |
16.98 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation |
16.99 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation |
16.100 ESTALIS Matrixpfl 50/250 24 Stk |
16.101 ESTALIS Matrixpfl 50/250 24 Stk (Bundle) |
16.102 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation |
16.103 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation |
16.104 Indication 10009900 |
16.105 Indication 10019927 |
16.106 Indication 10021782 |
16.107 Indication 10027400 |
16.108 Indication 10028881 |
16.109 Indication 10030247 |
16.110 Indication 10031285 |
16.111 Indication 10043971 |
16.112 Indication 10061091 |
16.113 Indication 10075566 |
16.114 Indication 10084529 |
16.115 KEYTRUDA Inf Konz 100 mg / 4 ml |
16.116 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle) |
16.117 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation |
16.118 Limitation 254837009 |
16.119 Limitation 79886009 |
16.120 Limitation 840539006 |
16.121 MI Budesonidum-2.3mg-Tablet |
16.122 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch |
16.123 MI Nirmatrelvir-150mg-Tablet |
16.124 MI Pembrolizumab-100mg-Vial |
16.125 MI Ritonavirum-100mg-Tablet |
16.126 MI Solvent |
16.127 MI Trientinum-150mg-Tablet |
16.128 MI Trientinum-250mg-Capsule |
16.129 PAXLOVID Filmtabl 4x150mg/2x100mg |
16.130 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle) |
16.131 Paxlovid, Filmtabletten Patienteninformation |
16.132 PhP Budesonidum-Suspension |
16.133 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch |
16.134 PhP Pembrolizumab-100mg-Vial |
16.135 PhP Trientinum-150mg-Tablet |
16.136 PhP Trientinum-150mg-Tablet |
16.137 PhP-Nirmatrelvir-150mg-Filmcoatedtablet |
16.138 PhP-Ritonavirum-100mg-Filmcoatedtablet |
16.139 Professional Information Paxlovid, Filmtabletten Fachinformation |
16.140 Reimbursement SL 17418 |
16.141 Reimbursement SL 17973 |
16.142 Reimbursement SL 20416 |
16.143 Reimbursement SL 21070 |
16.144 Reimbursement SL 21208 |
16.145 Reimbursement SL 21529 |
16.146 TRIOGEN Kaps 250 mg Ds 100 Stk |
16.147 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle) |
16.148 Triogen, Kapseln Fachinformation |
16.149 Triogen, Kapseln Patienteninformation |